GlassScriptPhysician profile
Rebecca Warnock
NPI 1760948871
$4,511.63
in general payments reported to CMS, 2019-2025
12 companies · $1,293 in 2025
The $1,293 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $352 · 2022: $285 · 2023: $1,471 · 2024: $1,110 · 2025: $1,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,839 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,838.71 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,403.76 | 2023-2025 | Aveir, Merlin@Home, Jot Dx |
| Boston Scientific Corporation | $975.62 | 2023-2025 | Lux-Dx Insertable Cardiac Monitor, Zoom Wireless Transmitter, Emblem Mri S-Icd |
| Medtronic, INC. | $893.16 | 2021-2025 | Micra, Linq II, Azure Xt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $334.97 | 2022-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $292.57 | 2021-2024 | Xarelto |
| Irhythm Technologies, INC. | $226.17 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $125.00 | 2023 | |
| Biotronik INC. | $115.76 | 2022-2024 | Renamic Neo |
| Philips North America LLC | $86.34 | 2024 | (5091) Amb Mon & Diag Und, (Ck4) Mcot |
| Altathera Pharmaceuticals LLC | $20.26 | 2025 | Sotalol Hydrochloride |
| Pfizer INC. | $19.64 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $18.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Warnock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.